Recap: Matinas BioPharma Hldgs Q1 Earnings

Matinas BioPharma Hldgs MTNB reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Matinas BioPharma Hldgs reported in-line EPS of $-0.03 versus an estimate of $-0.03.

Revenue was up $1.10 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 6.86% increase in the share price the next day.

To track all earnings releases for Matinas BioPharma Hldgs visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

MTNB Logo
MTNBMatinas BioPharma Holdings Inc
$0.81206.70%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
21.34
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Comments
Loading...